Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS

Annals of Pharmacotherapy

Volumn 30, Issue 6, 1996, Pages 612-614

  Al Hedaithy, Mogbil A ^a   Noreddin, Ayman M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DOBUTAMINE; DOPAMINE; FLUCONAZOLE; MULTIVITAMIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAPHYLAXIS; ARTICLE; BLOOD CULTURE; BLOOD PRESSURE; BRONCHIECTASIS; CASE REPORT; FEMALE; HEADACHE; HUMAN; HYPERSENSITIVITY REACTION; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPTIC SHOCK; SPUTUM CULTURE;

EID: 0029973655     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000609     Document Type: Article

References (33)

1. Jooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Eng] J Med 1991:324:384-94.
2. Chium J, Nussbaumm J, Bozzette S, Tilles JG, Young LS, Leedom J, et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol. rifampin and ciprofloxacin. Ann Intern Med 1990;13:358-61.
3. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med 1993;329:898-904.
4. Deamer RL, Prichard JO, Loman GJ. Hypersensitivity and anaphylactoid reactions to ciprofloxacin. Ann Pharmacother 1992;26:1081 -4.
5. Jaffe HS, Abrams DI, Ammann AJ, Lewis BJ, Gelden JA. Complications of co-trimoxazole in treatment of AIDS associated Pneumocystis carinii pneumonia in homosexual men. Lancet 1983:2:1109-11.
6. Gordin FM, Simon GL, Wofsey CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984:100:495-9.
7. Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex. Br Med J 1989;298:605.
8. Kennedy CA, Goetz MB, Mathisen GE. Ciprofloxacin-induced anaphylactoid reaction in patients infected with the human immunodeficiency virus. West J Med 1990;153:563-4.
9. Wurtz RM, Abrams D. Becker S, Jacobsen MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet 1989;1:955-6.
10. Lee BL, Safrin S. Interactions and toxicities of drugs used in patients with AIDS. Clin Infect Dis 1992;14:773-9.
11. Medina I, Mills J, Leoing G, Hopewell PC, Lee B, Modin G, et al. Oral therapy or Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 1990;323:776-82.
12. Wharton JM, Coleman DL, Wofsy CB, Luce JM, Blumfeld W, Hadley WK, et al. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:3744.
13. Sattler FR, Cowan R, Nielson DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study. Ann Intern Med 1988;109:280-7.
14. Hughes WT, Feldman S, Chaudhary SC, Ossi MJ, Cox F, Sanyal SK. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 1978;92:285-91.
15. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663-71.
16. Winston DJ, Lau WK, Gale RP, Young LS. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 1980;92:762-9.
17. Vanderven ATM, Koopmans PP, Vree TB, Vander Meer JWM. Drug intolerance in HTV disease. J Antimicrob Chemother 1994;34:1-5.
18. Carr A, Tindall B, Penny R, Cooper DA. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin Explmmunol 1993;94:21-5.
19. Lee BL, Wong D, Benowitz NL, Sullam PM. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther 1993;53:529-35.
20. Harb G, Alldredge B, Coleman E, Jacobson M. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus (HTV) disease. J AIDS 1993;6:919-26.
21. Kemper CA, Meng T, Nussbaun J, Chiu J, Feigal DF, Bartok AE, et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four drug regimen. Ann Intern Med 1992;! 16:446-72.
22. Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, et al. Ciprofloxacin: an update on clinical experience. Am J Med 1987;82: 381-6.
23. Gentry LO, Rodringuez GG. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother 1990;34:40-3.
24. Wolfson JS, Hooper DC. Overview of fluoroquinolone safety. Am J Med1991;91:1535-615.
25. Wagal N, Yamaguchi F, Sekiguchi M, Tawara K. Phototoxic potential of quinolone antibacterial agents in Balb/c mice. Toxicol Lett 1990;54:299-308.
26. Choe U, Rothschild BM, Laitman L. Ciprofloxacin-induced vasculitis. N Engl J Med 1989;320:257-8.
27. Slama TG. Serum sickness-like illness associated with ciprofloxacin. Antimicrob Agents Chemother 1990;34:904-5.
28. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989;111:1041-3.
29. Valdivieso R, Pola J, Losada E, Subiza I, Armentia A, Zapata C. Severe anaphylactoid reaction to nalidixic acid. Allergy 1988;43:71-3.
30. Stricker BH, Slagboom G, Demaeseneer R, Slootmaeker SV, Thijs I, Olssom S. Anaphylactic reactions to cinoxacin. Br Med J 1988;297:1434-5.
31. Monke JP, Campoli-Richards DM. Ofloxacin: a review of its antibacterial activity, pharmacokinetics properties and therapeutic use. Drugs 1987;3:346-91.
32. Physician's desk reference. Oradell, NJ: Medical Economics, 1993:1573.
33. Gonzalez JP, Henwood JM. Pefloxacin: a review of its antimicrobial activity, pharmacokinetics properties and therapeutic use. Drugs 1989;37: 628-68.